Getagraph.com logo
S&P 500
(-0.10%) 5 017.31 points
Dow Jones
(0.02%) 37 762 points
Nasdaq
(-0.22%) 15 649 points
Oil
(0.56%) $83.15
Gas
(2.45%) $1.754
Gold
(0.61%) $2 402.90
Silver
(0.25%) $28.47
Platinum
(0.14%) $955.50
USD/EUR
(0.26%) $0.939
USD/NOK
(0.50%) $11.05
USD/GBP
(0.12%) $0.804
USD/RUB
(0.10%) $94.15

Realtime updates for Pharma Mar, S.A. [PHM.MC]

Exchange: EURONEXT Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-04-23)

Expected move: +/- 0.00%

Last Updated18 Apr 2024 @ 11:35
25% discount on Stockinvest.us - Use code: Podcast

0.38% € 26.62

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 11:35):

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally...

Stats
Today's Volume 18 867.00
Average Volume 38 240.00
Market Cap 474.88M
EPS €0 ( 2024-02-28 )
Next earnings date ( €0 ) 2024-04-23
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E 443.67
ATR14 €0.0420 (0.16%)

Volume Correlation

Long: 0.04 (neutral)
Short: -0.50 (neutral)
Signal:(58.392) Neutral

Pharma Mar, S.A. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pharma Mar, S.A. Correlation - Currency/Commodity

The country flag -0.09
( neutral )
The country flag -0.31
( neutral )
The country flag 0.00
( neutral )
The country flag 0.11
( neutral )
The country flag -0.03
( neutral )
The country flag -0.20
( neutral )

Pharma Mar, S.A. Financials

Annual 2023
Revenue: €158.15M
Gross Profit: €144.86M (91.60 %)
EPS: €0.0635
Q4 2023
Revenue: €40.51M
Gross Profit: €38.06M (93.95 %)
EPS: €-0.390
Q3 2023
Revenue: €37.45M
Gross Profit: €34.31M (91.60 %)
EPS: €0.0846
Q2 2023
Revenue: €46.21M
Gross Profit: €44.32M (95.91 %)
EPS: €0.280

Financial Reports:

No articles found.

Pharma Mar, S.A.

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators